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Abstract
The cell envelope of mycobacteria, a group of Gram positive bacteria, is composed of a plasma membrane and a Gram-
negative-like outer membrane containing mycolic acids. In addition, the surface of the mycobacteria is coated with an ill-
characterized layer of extractable, non-covalently linked glycans, lipids and proteins, collectively known as the capsule,
whose occurrence is a matter of debate. By using plunge freezing cryo-electron microscopy technique, we were able to
show that pathogenic mycobacteria produce a thick capsule, only present when the cells were grown under unperturbed
conditions and easily removed by mild detergents. This detergent-labile capsule layer contains arabinomannan, a-glucan
and oligomannosyl-capped glycolipids. Further immunogenic and proteomic analyses revealed that Mycobacterium
marinum capsule contains high amounts of proteins that are secreted via the ESX-1 pathway. Finally, cell infection
experiments demonstrated the importance of the capsule for binding to cells and dampening of pro-inflammatory cytokine
response. Together, these results show a direct visualization of the mycobacterial capsular layer as a labile structure that
contains ESX-1-secreted proteins.
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Introduction
Mycobacteria are the causative agent of tuberculosis and other
chronic diseases such as leprosy and causes about 1.7 million
deaths annually. The interaction of Mycobacterium tuberculosis with
its macrophage host cell is largely dictated by its unique cell
envelope components that are able to elicit immuno-modulatory
responses similar to that of the pathogen [1].
The mycobacterial cell envelope has a complex structure
composed of a typical phospholipid bilayer plasma membrane
(PM), an outer membrane and an outermost layer known as the
capsule in the case of pathogenic species [2]. The mycobacterial
outer membrane henceforth referred to as ‘mycomembrane’ is
mainly composed of long chain (C60-C90) mycolic fatty acids with
free intercalating glycolipids and is covalently linked to the
arabinogalactan-peptidoglycan layer [3,4]. The chemical nature of
mycomembrane has been examined in detail [4] and recent cryo-
transmission electron microscopy (EM) data shows that it
organizes into a structure analogous to the outer membrane of
Gram-negative bacteria [5,6]. The structural organization of this
highly insoluble matrix is invariable among different mycobacte-
rial species and is responsible for the low permeability of the
mycobacterial cell envelope [4].
The capsule is visible as an electron transparent zone (ETZ)
surrounding the mycobacterial cell envelope [2,7] in conventional
EM preparations [8,9]. This layer was not, however, observed by
cryo-EM [5,6], questioning somehow its existence. This layer,
mainly composed of polysaccharides, proteins and small amounts
of lipids, is considered to have a different molecular composition in
pathogenic and non-pathogenic species [2,10,11]. The presence of
the capsular layer is influenced by the culturing conditions used;
laboratory cultures commonly grown in the presence of detergent
with agitation to prevent clumping [12] usually shed the capsule
into the medium [13,14].
In the present study, we adopt a close to native-state approach
to study the mycobacterial cell envelope and demonstrate that
mycobacteria express a distinctive outer layer. We have charac-
terized the mycobacterial capsule layer by immunological and
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proteomic analyses and showed that some mycobacteria have
ESX-1 secreted proteins in their capsule layer. ESX-1 encodes a
type VII secretion system that mediates the secretion of potent T
cell antigens such as ESAT-6 (EsxA) and CFP-10. Furthermore,
the presence of a capsule not only enhanced the Mycobacterium-
macrophage interaction but also dampened the pro-inflammatory
cytokine response.
Results/Discussion
Cell envelope organization of mycobacterial cells
The ultra-structure of the mycobacterial cell envelope was
investigated using 30 nm vitreous sections, as previously described
[15]. As a control for structural preservation of the envelope
morphology, we also examine vitreous sections of the Gram-
negative bacterium Shigella flexneri and the Gram-positive bacterium
Staphylococcus epidermidis. The width of the PM and outer membrane
or cell wall in both species are consistent with previous results
[16,17] (Figure S1, Table S1). The vitreous sections of four
mycobacterial species [M. tuberculosis, M. marinum, Mycobacterium bovis
Bacille Calmette-Gue´rin (BCG) and Mycobacterium smegmatis]
examined appeared similar and show a well preserved cell envelope
composed of a PM and a mycomembrane with a bilayer profile
(Figure S1C, S2 and S3). Although the intensity of the mycobac-
terial PM is similar to that of S. flexneri and S. epidermidis, the width
(<7 nm) is at least 16% wider (Table S1). The mycomembrane,
with an apparent thickness of <8.3 nm is also thicker than the
6.8 nm thick outer membrane of S. flexneri. This slight increase in
thickness is similar to recently published data [5,6].
Cryo-electron tomography analysis was performed to determine
the 3D architecture of the envelope (Figure S1D-F). In the
reconstructed slices of M. smegmatis cell envelope, two additional
layers are present in the periplasmic space. These layers are similar
to those observed as L1 and L2 in [5] and as the granular layer
and the medial wall zone referred to in [6]. The L1 layer appears
immediately after the plasma membrane while the L2 layer
appears closely apposed to the mycomembrane and may possibly
be the peptidoglycan/arabinogalactan matrix. Taken together,
these findings show that the cell envelope morphology of the
mycobacteria is structurally related to, but more complex than
that of the Gram-negative bacteria.
Visualization of the mycobacterial capsular layer and its
disruption by Tween and agitation
The capsule, being a substantial component of the cell envelope,
should be visible in vitreous sections as an extra layer extending
from the mycomembrane. Yet, in our analyses and previous
studies [5,6], such a layer is not visible (Figure S1C, S3). We
reasoned that the detection of this layer may have been obscured
by the presence of the dextran cryoprotectant, which may have an
electron density similar to that of the capsule. Alternatively, the
capsule might have been removed by growing the cells in the
presence of detergent and agitation in order to prevent clumping
[2,13,14].
To investigate this, mycobacterial cells were cultured with or
without Tween-80 and agitation and subsequently frozen in a
close to native-state by the plunge freezing method [18] for direct
visualization by EM (Figure 1). This method does not rely on the
use of cryoprotectants and allows intact cells to be frozen in their
medium of culture. The Gram-negative bacterium S. flexneri was
used as a control (Figure 1A). When grown without any
perturbation, all mycobacterial species examined, showed a thick
outermost capsule-like layer (Figure 1C to 1F). To our knowledge,
this is the first time this layer is visualized in a close to native state
surrounding both pathogenic and nonpathogenic mycobacterial
species. In comparison, cells grown with perturbation show this
layer to be partially or completely removed (Figure 1B), meaning
that growing mycobacteria under routine culturing conditions
involving perturbation promotes shedding of this layer.
To demonstrate that this outermost layer is distinct from the
mycomembrane, we sought to localize OmpATb porin known to
be present in the mycomembrane [19] by labeling fixed cryo-
sections of M. smegmatis cells over-expressing this protein [20] with
anti-OmpATb serum and probed with protein-A attached to
10 nm gold. When grown in the presence of perturbation, the
mycomembrane was efficiently labeled with the antibody
(Figure 2A). In comparison, cells grown in the absence of the
detergent maintain the outermost layer, though the OmpATb
antibody only specifically labeled the underlying mycomembrane
(Figure 2B). Parental M. smegmatis strain, naturally devoid of
OmpATb, cultured under unperturbed state lacks any labeling,
demonstrating the specificity of this antibody (Figure 2C). These
results indicate that the outermost layer removed by perturbation
is distinct and not part of the mycomembrane.
Characterization of the mycobacterial capsular layer by
immuno gold-EM
To confirm that the observed outermost layer is indeed the
capsule, immuno gold-EM analysis of whole bacteria using
antisera against known capsular components was performed.
Whole bacteria were immobilized on EM grids and incubated with
specific antibodies and gold probes. This method also allowed us
to visualize and quantify the different components. Since a-glucan
is described to be the major capsular polysaccharide [2,11], we
first investigated this using an a-glucan-specific monoclonal
antibody [21]. The bacterial surface of cells grown in unperturbed
state was distinctly labeled homogenously with this antibody
(Figure 3), whereas cells grown in perturbed state showed weak or
no labeling. Fixation of the cells was important for efficient
labeling, since the same unperturbed culture without any fixation
Author Summary
The genus Mycobacterium contains a number of important
pathogens, such as Mycobacterium tuberculosis. The highly
characteristic cell envelope of these bacteria plays a crucial
role in the infection process. The most apparent difference
with other bacteria is the recently described outer
membrane composed of unique (glyco)lipids. However,
on top of this membrane mycobacteria also have an ill-
defined capsular layer. In this paper, we studied this
capsular layer using different electron microscopy tech-
niques and mass spectrometry. Using close to native state
preparation method, we show that both pathogenic and
non-pathogenic mycobacteria have a labile capsular layer
that covers the outer membrane. This capsular layer, in
addition to containing arabinogalactan, glycan and man-
nose-containing glyco-lipids, also surprisingly contains a
large amount of ESX-1-secreted proteins in Mycobacterium
marinum. Furthermore, we also show that the capsule
plays a role in the binding of macrophages and the
induction of cytokines. Collectively, these results show for
the first time that the capsule can be visualized on both
pathogenic and non-pathogenic mycobacteria. In addition,
growing mycobacteria under standard laboratory condi-
tions in the presence of detergent with agitation promotes
capsular shedding and influences the biological character-
istics of the bacteria.
Visualization of Mycobacterial Capsule by Cryo-EM
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showed reduced or weak labeling. Non-acylated arabinomannan
(AM) is also a described component of the capsule [11,22]. Using
antibodies directed against arabinomannan structural motifs, our
experiments confirmed the presence of AM in the capsule (Figure
S4) Subsequently, we tried to localize the glycolipid phosphatidy-
linositol mannosides (PIMs), which is possibly associated with the
capsule [23]. For this we used an antibody that on M. smegmatis
specifically recognizes the PIM6 epitope, as it does not interact
with M. smegmatis pimE mutant (Figure 3F) [24,25]. The antibody
labeled the surface of intact cells very efficiently, supporting the
presence of specific PIM epitopes on M. smegmatis and possibly
other mannoconjugates and PIM on the pathogenic mycobacteria
except for M. marinum which is poorly labeled with this antibody.
Importantly, all of the antibodies significantly labeled less when
the bacteria were grown agitated in the presence of detergent
(Figure 3A, 3D and S4). Agitation in the absence of detergent
contributes to the erosion of the capsule albeit lesser than when
detergent is also included, conversely, the addition of detergent
alone also shows less capsular disruption, thus the effect is additive.
In addition to glycans and glycolipids, the capsule also contains
proteins [2,10], although these are generally not well described.
One putative capsular protein recently described by Carlsson et al
[26] is the ESX-1-associated protein EspE [formerly known as
Mh3864 [27]], which together with EspB is also secreted by ESX-
1 encoded type VII secretion system [26,28]. To investigate EspE
localization, whole cells were labeled with anti-EspE antibody
which homogenously labeled the surface of M. marinum and M.
tuberculosis. A preference of EspE for the polar region as previously
reported [26] was not observed (Figure 3G-I). The localization of
EspE in a M. marinum strain (Fas 3.1) with a transposon insertion in
eccCb1 [formerly known as Mh1784 [27]] which blocks ESX-1-
dependent secretion (van der Sar et al, in preparation), showed no
specific labeling, demonstrating both the specificity of the antibody
used and the ESX-1 dependence of EspE export. Finally, EspE
labeling was not strongly affected by Tween-80, suggesting that
this protein is more tightly associated with the cell envelope.
Capsule of M. marinum contains secretion specific
proteins
To screen for specific (ESX-secreted) proteins within the capsule
for which no antibodies are available, we analyzed capsular extracts
by liquid chromatography mass spectrometry (LC-MS). For this,
Figure 1. Visualization of the capsule in its native state. Cryo electron micrographs of intact S. flexneri cell plunge frozen (A) depicts the typical
cell envelope profile using this method of sample preparation. (B) M. smegmatis cells grown with both chemical and mechanical perturbation shows a
cell envelope with morphology similar to S. flexneri. Similar cells cultured in an unperturbed state before freezing (C) shows the presence of an extra layer
(bracket) surrounding themycomembrane. Corresponding layers are also observed surrounding the mycomembranes ofM. tuberculosis (D),M. marinum
(E), andM. bovis BCG (F). The density profiles in B’ and C’ were obtained from images corresponding to B and C respectively. Images were averaged over a
width of 75 pixels. The outermost layer varies in thickness from negligible to considerable (40 nm; see Table S1) indicating the unstable nature of this
layer. Arrow heads point to plasma membrane (PM; magenta) and outer membrane/mycomembrane (MOM; blue). Scale bars: 100 nm.
doi:10.1371/journal.ppat.1000794.g001
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capsular material was isolated from cells grown under unperturbed
conditions by treating the cells with the mild detergents Tween-80
(1%) or Genapol-X080 (0.25%) (Figure 4). First, we analyzed the
isolated fractions and the cell pellet for the presence of capsular a-
glucan by a spot-blot assay. Consistent with our EM data, both M.
marinum and M. smegmatis cells contained more a-glucan when they
were grown in the absence of Tween-80 (Figure 4A and S5,
respectively). Furthermore, spot-blot analysis showed that a-glucan
was extracted by these mild detergents. These fractions were
subsequently analyzed by SDS-PAGE. Extracts from bacteria
grown in the absence of detergent repeatedly contained higher
amounts of proteins, which indicate that their presence depends on
an intact capsule (Figure 4B). In addition, more proteins were
extracted by Genapol as compared to Tween.
The Genapol-extracted fractions from bacteria grown in the
absence of Tween-80 were analyzed by LC-MS (Table 1). The
highest number of peptides found in the M. marinum extract
belonged to EspE, whose predicted molecular weight of 40 kDa
corresponds to the size of the most abundant protein in the extract
(Figure 4B). Interestingly, other ESX-1-associated proteins such as
EspB, EspF (Mh3865), EspK (Mh3879c), ESAT-6 (EsxA), CFP-10
and PPE68_1 were also present in high amounts. In addition,
several other PE and PPE proteins were found in the Genapol
extracts. OmpA was not detected in the Genapol-extracted
material, confirming that this treatment did not extract proteins
from the mycomembrane. These data show that M. marinum has a
specific set of proteins within its capsule.
The situation was different for M. smegmatis and M. tuberculosis.
The capsular extracts of these two species did not show any major
protein bands (Figure 4B). This observation was confirmed by LC-
MS analysis, which showed that the major proteins were cytosolic
proteins such as GroEL2, DnaK and translation elongation factor
Tu (Table S2 and S3). The presence of some of these proteins in the
capsule was also recently described by Hickey et al. [29]. In addition
to these predominantly cytosolic proteins only very small amounts of
putative capsular proteins, such as the ESX-1-associated proteins,
were identified by LC-MS (data not shown). This could indicate that
the capsular proteins of M. smegmatis and M. tuberculosis might be
more tightly associated with the cell envelope than in M. marinum
and are therefore missed during analysis.
The major capsular proteins of M. marinum are secreted
via ESX-1
The capsule of M. marinum contains a high amount of ESX-1
associated protein. To investigate whether these proteins depend
on ESX-1 for their localization, Genapol extracted proteins of the
M. marinum Fas 3.1 eccCb1 mutant were analyzed (Figure 4C). The
protein pattern of the ESX-1 mutant differed considerably from
the wild-type protein pattern. Importantly, the 40 kDa product
corresponding to EspE was not detectable in the capsular extract
of the ESX-1 mutant (Figure 4C and D), suggesting that the
capsular localization of EspE depends on an active ESX-1
secretion system in M. marinum as previously reported [26]. This
result was also confirmed by LC-MS analysis (Table 1) and shows
that EspF, EspK and the PPE proteins associated with the ESX-1
pathway are dependent on an active ESX-1 system for capsular
localization and are therefore new putative ESX-1 substrates. The
presence of other PE and PPE proteins in the capsule was not
affected by the ESX-1 mutation, which is in agreement with the
recent observation that many of these proteins, including the
capsule PPE protein MMAR_1402, depend on another secretion
system, ESX-5 for their export [30].
Capsular layer promotes binding to macrophages and
inhibits pro-inflammatory cytokine response
As demonstrated above, growing mycobacteria in the presence of
detergent with agitation, promotes capsular shedding and thus may
influence the biological characteristics of the bacteria. To investigate
this issue and to potentially gain insight into the biological relevance
of the capsule, M. bovis BCG was grown under unperturbed
conditions after which the bacteria were treated with 1% Tween-80
to remove the capsule. First, we investigated the consequence of
capsule removal on the ability of the bacteria to bind to human
monocyte-derived macrophages. As shown in Figure 5A, removal of
the capsule significantly reduced bacterial binding at all tested
multiplicities of infection (MOIs), suggesting that the presence of the
capsule promoted association to the macrophages. Next, we
investigated whether the presence of a capsule may also
differentially modulate the macrophage pro-inflammatory cytokine
responses. As shown in Figure 5B, non-detergent-treated M. bovis
BCG induced significantly lower amounts of IL-12p40, IL-6, and
TNFa (,30%) as compared to the detergent-treated bacteria at
both MOIs tested. The only exception was IL-6, for which the
difference at MOI 8 was non-significant. Reduced cytokine
induction by untreated (encapsulated) M. bovis BCG was observed
in both resting macrophages (Figure 5B) and in macrophages
primed with LPS (data not shown). Interestingly, treatment with
detergent did not differentially affect the macrophage response for
non-pathogenic M. smegmatis (Figure 5C). Overall, these findings
demonstrate that at least for M. bovis BCG the capsule is involved in
facilitating macrophage infection and, simultaneously, plays a role
in dampening the pro-inflammatory macrophage response. Fur-
Figure 2. Distinction between the mycomembrane and the
outermost layer. Immuno-labeling of outer membrane porin
OmpATb on thin sections of M. smegmatis overexpressing OmpATb
(mechanically agitated and detergent treated culture) (A) and non-
perturbed culture (B) as compared to M. smegmatis wt (C). Outermost
layer indicated by bracket. Scale bar: 50 nm.
doi:10.1371/journal.ppat.1000794.g002
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thermore, these data imply that growing mycobacteria in the
presence of detergent, as is done under many standard laboratory
circumstances, may have important consequences for the biological
characteristics of these bacteria.
Summary and biological implications
In this study we used a plunge freezing method [18] that avoids
artifacts introduced by chemical fixation and thus gives a close to
native estimation of the thickness for these in vitro grown bacteria.
We demonstrated the presence of the capsular layer in the cell
envelope of both pathogenic and nonpathogenic mycobacterial
species and determined its thickness to be around 30 nm (Table S1),
taking into account the instability of the capsule in vitro; both groups
have been previously shown to differ in the amount of extracellular
material found in static and non-detergent-treated medium, which
is interpreted as representing part of the capsule shed from growing
cells [10,11]. One possibility of circumventing this instability is to
measure this layer inside phagocytic cells in the vitreous state. It is
however currently very difficult to freeze large mammalian cells
under physiological conditions in a vitreous state [31].
The detection of capsular components a-glucan, arabinoman-
nan, and oligo- and poly-mannosylated compounds on the surface
of whole cells by immuno gold-EM is in agreement with chemical
data about the nature of the capsule [4,10,11]. The presence of
PIMs exposed at the surface of mycobacteria was already
demonstrated [32,33,34], however here we showed that PIM, a-
glucan, and ESX secreted proteins are accessible to antibodies on
intact bacteria. Mycobacterial a-glucan is implicated in the
regulation of phagocytosis [35,36], modulation of immune
response [1,21], and persistence of infection [37]. In this study
we have shown that binding to macrophages and a dampening of
the pro-inflammatory cytokine response is observed for encapsu-
lated M. bovis BCG, which suggests that components of the
capsule, such as glycans, play a role in immune response.
The identification of many ESX-5 and ESX-1 secreted proteins
(ESAT-6 and CFP-10, EspB, EspE, EspF, EspK and an ESX-1
associated PPE) in the capsule, a number of which have not been
identified previously as being secreted via ESX-1 (EspF, EspK and
PPE68_1) was surprising. These proteins were only detectable in
the detergent-labile capsule fraction of M. marinum. Some ESX-1-
secreted proteins have an essential role in the interaction with the
host [38,39,40], and more specifically in bacterial translocation
from the phagosome into the cytosol [41]. The fact that EspE can
only be partly removed by Tween-80, suggests a distinction
between proteins that are freely associated with the capsule and
those more tightly associated with the rest of the cell envelope. In
Figure 3. Effect of detergent on the localization of capsular components and the detection of ESX-1 proteins. M. smegmatis (A and B),
M. tuberculosis (D and E) and M. marinum (G and H) were grown under both perturbed (A,D and G) and unperturbed conditions (B,E and H), fixed and
probed with anti-a-glucan (A–B) and anti PIM/capLAM (D–E) to demonstrate that this extra layer is of capsular origin. (G–H) demonstrates the
presence of anti-EspE on bacterial surface/capsule. Histogram (C,F and I) respectively displays the variations in anti glucan, anti PIM/capLAM and anti-
EspE labeling of bacteria due to change in the culturing conditions using M. smegmatis DPimE k.o. and M. marinum fas 3.1 eccCb1 mutant as controls.
The ordinate (defined as percentage of bacteria with$10 gold particles) represents the average6 standard error of labeled cells from 3 independent
experiments. Scale bars: 250 nm.
doi:10.1371/journal.ppat.1000794.g003
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this context, these ESX-1 associated proteins may form a surface-
exposed macromolecular structure through (and/or within) the
capsule, specialized for the interaction with the host (Figure 6).
Together, we showed that the mycobacterial capsule contains
various components that manipulate the host, making this layer an
attractive target for vaccine and drug development.
Materials and Methods
Bacterial strains and growth conditions
M. tuberculosis 6020 strain [42], M. bovis BCG strain Copenha-
gen, M. smegmatis mc2155, M. smegmatis-OmpATb [20], M. marinum
E11 strain and the E11 fas 3.1 eccCb1 mutant (van der Sar et al, in
preparation) were grown at 37uC (or 30uC for M. marinum) in
Middlebrook 7H9 media (Difco) supplemented with 10% oleic
acid-albumin-dextrose catalase (OADC) (BBL) with or without
0.05% Tween 80 where applicable. For the growth of M.
smegmatis-OmpATb and M. bovis BCG expressing dsRed, 25 mg
and 50 mg mL21 kanamycin and 50 mg mL21 hygromycin were
added, respectively. S. flexneri ipaC strain SF621 [43] was grown in
tryptic casein soy broth (Sigma) at 37uC. S. epidermidis was grown in
Luria-Bertani broth (Difco) at 37uC.
Cryo-EM
Vitrification, vitreous sectioning and tomography is as described
in Supplementary information (SI) Text and [44]. For plunge freezing,
bacteria were taken directly from culture medium for processing
without further centrifugation. A 4 ml droplet of various
mycobacteria sample were applied to a glow-discharge quantifoil
copper grids (Quantifoil Micro Tools, Jena, Germany) mounted in
an environmentally controlled chamber at 100% humidity, blotted
and frozen in vitreous ice by plunging into liquid ethane using the
vitrobot (FEI). Grids were transferred to a Gatan model 626
cryoholder (Gatan, Pleasanton, CA) under liquid nitrogen and
inserted into a Tecnai 12 (FEI, Eindhoven, Netherlands) operating
at 120 kV. The vitreous state of the preparation was confirmed by
electron diffraction. Low-dose images, with exposures between 10
and 20 electrons per A˚2 and under-focus values of 2 to 4 mm were
recorded with a 409664096 pixel CCD camera (Gatan) at
618,000 2623,000 magnification.
Immuno gold-EM
Bacteria cells were fixed by addition of an equal volume of 0.4M
PHEM buffer containing 4% paraformaldehyde and 0.4%
glutaraldehyde to the culture and incubating for 2 hours at room
temperature [41].
For whole mount cells, samples were taken directly from the
fixed culture without pelleting and incubated for 5 minutes on
carbon coated formvar grids. The rabbit antibody used is
OmpATb [19]. The following murine IgM monoclonal antibodies
(Mabs) were used: anti-Ara6 (F30-5) recognizes Ara6-motive in the
arabinan domain of (L)AMs [45,46]; anti-ManLAM (55.92.1A1)
Figure 4. Extraction of mycobacterial capsules by mild detergent. Cell surface extracts from mycobacteria that were cultured under perturbed
and unperturbed conditions (first normalized to proteins amounts of the pellet fraction) were prepared by incubation with 1% Tween-80 or 0.25%
Genapol X-080. (A and B) Extracted fractions were analyzed for the presence of a-glucan by a spot blot assay (A) and for the protein content by SDS-PAGE
and Coomassie staining (B). (C) Comparisons of the extracted proteins from wtM. marinum and an ESX-1 mutant by SDS-PAGE and Coomassie staining.
(D) Immunoblot showing the Genapol-extractability of EspE. Non-extracted material (P) was separated from the extracted material (S) by centrifugation
and equivalent amounts were loaded. As negative controls, the mycomembrane protein OmpA and the cytosolic protein GroEL were analyzed.
doi:10.1371/journal.ppat.1000794.g004
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Table 1. The 25 major cell surface extracted proteins of M. marinum.
Gene Spectral counts Description
wt ESX-1
MM5439 238 6 EspE
MM1129 99 79 PPE family protein
MM1402 89 166 PPE family protein
MM2459 83 57 PE_PGRS30
MM5440 71 17 EspF
MM3962 57 24 fatty acid synthase Fas
MM5449/0187* 56 29 EsxB/EsxB_1
MM1014 56 32 iron-regulated elongation factor Ef-tu Tuf
MM0186 48 1 PPE68_1
MM0759 48 53 chaperonin GroEL2
MM5047 42 80 PPE64
MM4089 37 21 ATP synthase alpha chain AtpA
MM5455 35 1 EspK
MM5364 34 16 polyketide synthase Pks13
MM1126 33 44 chaperonin GroEL1
MM1179 33 32 oxidoreductase
MM2586 31 29 conserved secreted protein
MM2914 30 7 catalase-peroxidase-peroxynitritase T KatG
MM0476 29 20 conserved membrane protein
MM0996 28 14 DNA-directed RNA polymerase beta chain RpoC
MM1767 28 7 multifunctional mycocerosic acid synthase membrane-associated Mas
MM2821 28 4 isocitrate lyase AceAb
MM1497 27 56 PPE family protein
MM5457 27 2 EspB
MM5450/0188 26 3 EsxA/EsxA_1
doi:10.1371/journal.ppat.1000794.t001
Figure 5. Capsular layer promotes binding to macrophages and inhibits the pro-inflammatory cytokine response. The results
represent the mean relative binding 6 standard error of the mean (SEM) of the pooled data from three independent donors. (A) The percentage of
macrophages associated with Tween. M. bovis BCG expressing dsRed bacteria was determined using flow cytometry. Binding of Tween-treated M.
bovis BCG at MOI 0.5 (1.13% +/2 0.24 (SD)) is set at 1. (B and C) Macrophages were stimulated with/without Tween treatment M. bovis BCG (B) or M.
smegmatis (C) at MOIs 2 and 8. Cells stimulated with PBS served as a control. After 24 h, the supernatants were harvested and the amount of IL-
12p40, IL-6, and TNF-a was determined using ELISA. The results represent the mean relative cytokine production (6 SEM) of the pooled data from at
least three independent donors. Cytokine production following stimulation with Tween-treated bacteria at MOI 8 is set at 100 [for M. bovis BCG, IL-6:
1208763056, IL-12p40: 29286618, TNFa: 3849066446; for M. smegmatis, IL-6: 61629617411, IL-12p40: 2269362100, TNFa: 122663617350 (all in pg
mL21 6 SEM)]. An asterisk indicates significant differences (p,0.05).
doi:10.1371/journal.ppat.1000794.g005
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binds the mannosyl caps on mannosyl-capped (L)AMs [46];
anti-PIM6 (F183-24) recognizes terminal a(1,2)-linked mannosyl
residues as present in PIM6 and the mannosyl caps on ManLAM
[25,45]. In M. smegmatis [which lacks the mannosyl-caps on
(L)AM] F183-24 specifically recognizes PIM6 with no reactivity to
other components [25]. The Mab against capsular a-glucans was
generated by O. Baba [47]. Immuno-labeling is essentially as
described [see Text S1 and [41]]. Labeled whole mount cells were
observed without further staining with a Tecnai 12 or CM 10
electron microscope (FEI, Eindhoven, Netherlands).
Cryo-sectioning and immuno gold labeling of fixed cells is
essentially as described in Text S1 and [41].
Capsule extraction
Mycobacteria were grown under conditions mentioned above to
an OD600 of,1, diluted 100 times in 7H9 without supplement or
Tween-80, but with 0.2% dextrose and grown to exponential
phase. Bacteria were harvested by centrifugation and washed 3
times in PBS. Bacteria were resuspended in PBS and incubated
with 1% Tween-80 or 0.25% Genapol X-080 for 30 min. at room
temperature before centrifugation to separate extracted fractions
from bacteria cells. To determine the presence of a-glucan the
extracted fractions were spotted on a nitrocellulose membrane, the
membrane was dried for 1 hour at 80uC, blocked by 5% skimmed
milk in PBS-T overnight and immuno-labeled using an anti-a-
glucan monoclonal antibody. For analysis of the protein content,
the extracted fraction was concentrated by TCA precipitation and
analyzed via SDS-PAGE and Coomassie staining or Western
blotting using anti-EspE [26].
Sample preparation for mass spectrometric analysis
Protein lanes from Coomassie stained SDS-PAGE gels were
excised and prepared for LC-MS analysis as described in Text S1.
Preparation of mycobacteria for macrophage-binding
and stimulation assays
M. bovis BCG, M. bovis BCG expressing dsRed, or M. smegmatis
were grown in Middlebrook 7H9 broth (Difco) supplemented with
10% ADC enrichment in the absence of Tween-80. Exponentially
growing bacteria were collected and washed once with 50 ml PBS.
The bacteria were resuspended in 20 ml PBS, split into two 10 ml
fractions, and incubated with/without 1% Tween-80 for 30 min
with rotation at room temperature. The treated and untreated
bacteria were washed twice with 25 mL Tris-buffered saline
supplemented with 1 mM MgCl2 and 2 mM CaCl2 (TSM)
containing 0.5% human serum albumin (HSA), passed through
a 5 mm filter (Millipore) for declumping (bacterial suspensions were
first centrifuged for 10 min at 2006g to prevent filter-clogging),
and diluted with TSM/0.5% HSA to the appropriate optical
density. Colony forming units were determined by plating the
suspensions on 7H10 agar supplemented with 10% Middlebrook
OADC.
Figure 6. The spatial organization of the mycobacterial cell envelope exhibiting the capsule. This scheme represents the relative size and
organization of the different layers of the envelope including the plasma membrane, mycomembrane, periplasmic space and capsular layer. The
positions of some of the constituents analyzed are depicted.
doi:10.1371/journal.ppat.1000794.g006
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Macrophage binding assay
M. bovis BCG expressing dsRed was added to 56105
macrophages [generated as described in Text S1 and ref.[21]] in
100 mL TSM/0.5% HSA at a MOI of 8, 2, or 0.5. After 45 min at
4uC, cells were washed twice with TSM/0.5% HSA and the
percentage of fluorescent cells was determined using a FACScan
Analytic Flow Cytometer (Becton Dickinson). Data was analyzed
using manufacturer’s software (CellQuest version 3.1f).
Macrophage stimulation assay
Macrophages were released by trypsiniation and resuspended in
culture medium (containing 50 U mL21 GM-CSF) at a concen-
tration of 1.256106 cells mL21. Eighty ml cell suspension (16105
cells) was transferred to a sterile 96-well U-bottom plate (Greiner)
and left for 16 h (37uC, 5% CO2) to allow cells to adhere.
Macrophages were stimulated with M. bovis BCG or M. smegmatis
(treated with or without 1% Tween-80) in the absence or presence
of 20 ng mL21 lipopolysaccharide (LPS) (from Salmonella enterica
serotype abortus equi (Sigma-Aldrich L5886). Unstimulated cells
served as controls in all experiments. Culture supernatants were
harvested after 24 h of incubation (37uC, 5% CO2) by
centrifugation and stored at 280uC for cytokine measurements
using an enzyme-linked immunosorbent assay (ELISA) according
to the manufacturer’s instructions (Invitrogen). Data were
statistically analyzed using a Student’s t test (two-tailed, two-
sample equal variance). Differences were considered to be
significant when p,0.05.
Supporting Information
Text S1 This supporting information file contains extra
materials and methods
Found at: doi:10.1371/journal.ppat.1000794.s001 (0.05 MB
DOC)
Figure S1 Mycobacteria have Gram-negative cell envelope
morphology. Cultured cells were resuspended in 20% dextran
for high pressure freezing before sectioning at a nominal thickness
of 30 nm. Cryo-electron micrographs of vitreous cryosections of S.
flexneri (A), S. epidermidis (B) M. smegmatis (C) show their various
membrane profiles. (D-F) 10 nm thick slice from a tomographic
reconstruction corresponding to A-C slightly denoised with a
median filter to show the various layers of the cell wall.
Tomographic slice of S. flexenri bacteria (D) illustrates the bilayer
nature of both the plasma membrane (magenta arrow head) and
the outer membrane (dark blue arrow head) typical for a bona fide
Gram-negative morphology and shows a strong morphological
similarity to the cell envelope profile observed for M. smegmatis (F);
periplasmic layers 1 and 2 (L1 and L2) are denoted by white arrow
heads. The slice in (E) shows a morphology typical for Gram-
positive bacteria and depicts a plasma membrane (magenta arrow
head) tightly bound by a thick and amorphous peptidoglycan layer
(PG black arrow) with no apparent outer layer as is in D and F.
Schematic drawing of the cross section of the corresponding cell
envelope morphologies of D-F is depicted in D’-F’. Plasma
membrane (PM; magenta arrow head) outer membrane (OM;
dark blue arrow head) peptidoglycan layer (PG black arrow). Scale
bars: 50 nm.
Found at: doi:10.1371/journal.ppat.1000794.s002 (2.41 MB TIF)
Figure S2 Vitreous sections of other mycobacteria strain. Cryo-
EM images of 30 nm frozen hydrated vitreous sections of M.
tuberculosis, M. marinum and M. bovis BCG vaccine strain. Scale bars:
50 nm.
Found at: doi:10.1371/journal.ppat.1000794.s003 (0.40 MB TIF)
Figure S3 Plot profiles of vitreous sections. Plot profiles of the
cryo-EM images of 30 nm vitreous section depicted in Figure 1
shows the multilayered spatial organization of the cell envelope of
S.flexneri (A), S.epidermidis (B) and M.smegmatis (C). Plasma
membrane (PM), granular layer (GL), outer membrane (OM),
peptidoglycan layer (PG) periplasmic layers 1 and 2 (L1 and L2)
and mycomembrane (MOM).
Found at: doi:10.1371/journal.ppat.1000794.s004 (8.53 MB TIF)
Figure S4 Localization of capsular components and the effect
of detergent layer. M. bovis BCG (A and B) and M. tuberculosis (D
and E) were grown under both perturbed (A and D) and
unperturbed (B and E) conditions, fixed and probed with anti-
arabinomannan antiserum (A-B) and anti-ManLAM antiserum
(D-E). Samples were prepared by mounting whole cell on a
carbon coated copper grid, labeling with antibodies and protein
A-gold (10 nm) and directly imaged without any staining.
Histogram (C and F) displays the variations in arabinomannan
(C) and ManLAM (F) labeling of bacteria due to change in the
culturing conditions. The ordinate (defined as percentage of
bacteria with $10 gold particles) represents the average
percentage 6 standard error of labeled cells from 3 independent
experiments. Scale bars: 250 nm.
Found at: doi:10.1371/journal.ppat.1000794.s005 (1.32 MB TIF)
Figure S5 Dot blot assay demonstrates presence of a-glucan.
The amount of a-glucan present on bacterial cells were analysed
by a spot blot assay for both M. marinum and M. smegmatis and
shows that these cells contain more a-glucan when they were
grown in the absence of Tween-80 as compared to cultures that
were grown with Tween-80, consistent with a more intact capsule
layer in the absence of detergent.
Found at: doi:10.1371/journal.ppat.1000794.s006 (1.14 MB TIF)
Table S1 Measurement of bacteria cell envelope compartments
Found at: doi:10.1371/journal.ppat.1000794.s007 (0.04 MB
DOC)
Table S2 The 25 major cell surface extracted proteins of M.
tuberculosis
Found at: doi:10.1371/journal.ppat.1000794.s008 (0.04 MB
DOC)
Table S3 The 25 major cell surface extracted proteins of M.
smegmatis
Found at: doi:10.1371/journal.ppat.1000794.s009 (0.04 MB
DOC)
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